Medline Inc (MDLN) Q4 2025 Earnings Call Highlights: Record Sales and Strategic Innovations ... [Yahoo! Finance]
Medline Inc. - Class A common stock (MDLN)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Annual Net Sales: $28.4 billion, up 12% versus prior year. Fourth-Quarter Net Sales: $7.8 billion, up 15% versus prior year. Adjusted EBITDA: $3.5 billion, a 3% increase versus prior year. Fourth-Quarter Adjusted EBITDA: $805 million, roughly flat year over year. Medline Brand Segment Sales: $13.7 billion for the full year, up 10% versus prior year. Surgical Solutions Sales: $6.2 billion for the full year, up 13%. Supply Chain Solutions Sales: $14.7 billion for the full year, up 13%. Free Cash Flow: $1.3 billion for the full year. Capital Expenditures: $447 million for the full year. Cash and Cash Equivalents: $1.9 billion at year end. Net Leverage: Reduced from 4.9 times to 3.1 times by year end. 2026 Organic Sales Growth Guidance: 8% to 9%. 2026 Adjusted EBITDA Guidance: $3.5 billion to $3.6 billion. Warning! GuruFocus has detected 4 Warning Sign with MDLN. Is MDLN fairly valued? Test your thesis with our free D
Show less
Read more
Impact Snapshot
Event Time:
MDLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDLN alerts
High impacting Medline Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MDLN
News
- Medline Inc. announces pricing of secondary offering of class A common stock [Yahoo! Finance]Yahoo! Finance
- Medline Inc. announces pricing of secondary offering of class A common stockGlobeNewswire
- Medline Inc. announces launch of secondary offering of Class A common stockGlobeNewswire
- Medline (MDLN) had its price target raised by Morgan Stanley from $48.00 to $52.00. They now have an "overweight" rating on the stock.MarketBeat
- Medline (MDLN) had its price target raised by Wells Fargo & Company from $42.00 to $47.00. They now have an "equal weight" rating on the stock.MarketBeat
MDLN
Earnings
- 2/25/26 - Miss
MDLN
Sec Filings
- 3/5/26 - Form EFFECT
- 3/3/26 - Form S-1
- 2/25/26 - Form S-8
- MDLN's page on the SEC website